FTXH
First Trust Nasdaq Pharmaceuticals ETF
1W: -2.3%
1M: -3.3%
3M: +4.7%
YTD: +23.0%
1Y: +37.8%
3Y: +64.2%
5Y: +68.4%
$40.73
-0.09 (-0.22%)
Weekly Expected Move ±2.1%
$39
$40
$41
$42
$42
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
Key Statistics
AUM$1.0B
Holdings50
Top 10 Wt54.0%
Volume53,732
Avg Volume483,474
Beta0.46
Portfolio Fundamentals
P/E40.0
P/B9.7
Div Yield1.52%
ROE24.0%
% Profitable57%
Inception2016-09-22
Sector Allocation
Healthcare
99.9%
Other
0.1%
Top 10 Holdings
| # | Name | Ticker | Weight % | Market Value | Shares |
|---|---|---|---|---|---|
| 1 | AbbVie Inc. | ABBV | 7.30% | $77.6M | 296,538 |
| 2 | Pfizer Inc. | PFE | 7.17% | $76.2M | 2,671,763 |
| 3 | Eli Lilly and Company | LLY | 7.15% | $76.1M | 65,736 |
| 4 | Johnson & Johnson | JNJ | 7.12% | $75.7M | 286,020 |
| 5 | Merck & Co., Inc. | MRK | 7.03% | $74.8M | 514,608 |
| 6 | Viatris Inc. | VTRS | 3.84% | $40.8M | 2,302,798 |
| 7 | Biogen Inc. | BIIB | 3.73% | $39.6M | 175,488 |
| 8 | Gilead Sciences, Inc. | GILD | 3.64% | $38.7M | 259,802 |
| 9 | Amgen Inc. | AMGN | 3.51% | $37.3M | 88,442 |
| 10 | Incyte Corporation | INCY | 3.48% | $37.0M | 305,104 |